Working… Menu

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02286089
Recruitment Status : Active, not recruiting
First Posted : November 7, 2014
Last Update Posted : December 3, 2020
CellCure Neurosciences Ltd.
Information provided by (Responsible Party):
Lineage Cell Therapeutics, Inc.